President Bill Clinton to Address Health Care Leaders at Inaugural
Patient Safety, Science & Technology Summit -- a Call to Action
to Eliminate Preventable Deaths and Reduce Costs
IRVINE, Calif., Dec. 3, 2012 /PRNewswire/ -- President
Bill Clinton, leading healthcare
professionals and industry executives will convene at the
first-ever Patient Safety, Science & Technology Summit,
January 13-14, 2013, at the
Ritz-Carlton, in Laguna Niguel,
Calif.
Each year, more than 200,000 patients die preventable deaths in
U.S. hospitals.1,2 At the inaugural Patient Safety,
Science & Technology Summit, leading physicians, hospital
administrators, medical technology manufacturers and patient
advocates will collaborate, commit, and pledge to improve patient
safety by taking action on three key areas in 2013:
- Failure to Rescue – Too many deaths and permanent
disabilities are a result of complications that were not recognized
and properly treated in a timely manner. These tragedies could be
avoided if hospitals improved processes and implemented systems
that facilitate patient safety.
- Medical Errors – A leading cause of death in
the United States, medical errors
are preventable adverse events or effects of care, the vast
majority being due to faulty systems and poorly designed processes
versus poor practices or incompetent practitioners.
- Overuse of Red Blood Cell (RBC) Transfusions – The most
frequent procedure performed in U.S. hospitals – with one in 10
inpatients receiving one or more units – RBC transfusion rates and
practices are highly variable by institution, procedure, and
physician. Yet studies show transfusions can increase mortality by
69% and morbidity by 88%, while restrictive transfusion practices
have been proven safe in multiple randomized controlled
trials.3,4
"Far too many patients suffer preventable harm including
receiving care that is disrespectful and undignified," said Dr.
Peter Pronovost, MD, Sr. Vice
President for Patient Safety and Quality at Johns Hopkins Medicine,
and Director of the Armstrong Institute for Patient Safety and
Quality. "Too often the safety of patients relies on the heroism of
clinicians rather than the design of systems. We need to
design a healthcare system that eliminates all types of preventable
harm; and to do so, clinicians must partner with patients,
their families, and technology
companies."
In any given hospital room, up to 15 medical devices, including
monitors, ventilators and infusion pumps, are connected to a
patient, but they don't communicate with each other. For example,
patient controlled analgesic pumps that deliver powerful narcotic
painkillers – where a known side effect is respiratory depression –
aren't linked to other devices that monitor breathing, leaving
patients at potential risk.
This Summit is not just about information, it is about
action.
The Patient Safety, Science & Technology Summit will
confront large problems with actionable ideas and innovations that
can transform the process of care for dramatic improvements in
patient safety and cost of care. Some of the best minds in
healthcare will engage and collaborate on high-impact patient
safety challenges through monitoring and feedback, predicting risk,
therapeutic advances, decision support, interoperability,
automating and integrating quality measures.
Joe Kiani, Chairman of the Masimo
Foundation for Ethics, Innovation & Competition in Healthcare,
stated: "We are excited to help gather some of the most passionate
advocates of humanity to focus on tangible, actionable recipes for
advancing patient safety. The goal is to have zero preventable
deaths in hospitals. Attendees will leave with action plans to
tackle and eliminate the three challenges discussed above. In
addition, we hope through President Clinton's challenge, and
encouragement of the world-renowned speakers from Dr. Joshua Adler to World Health Organization
special envoy Thomas Zeltner, the
health care industry will begin a new level of cooperation to help
every patient go home safely after their hospital procedure is
over."
In addition to President Clinton, other luminaries participating
in the Patient Safety, Science & Technology Summit include:
Joshua Adler, MD, Chief
Medical Officer of UCSF Medical Center, UCSF Benioff Children's
Hospital, and Medical Director of UCSF Ambulatory Care;
Richard Afable, MD,
President and CEO of Hoag Memorial Hospital Presbyterian;
Richard Boothman, JD,
Chief Risk Officer, University of
Michigan Health System;
David Classen, CMIO,
Pascal Metrics, Associate Professor of Medicine, University of Utah, Active Consultant in Infectious
Diseases, University of Utah School of
Medicine;
Michael Cohen, RPh, MS,
ScD (hon.), DPS (hon.), President of the Institute for Safe
Medication Practices;
Nancy Conrad, founder of
the Conrad Foundation and Spirit of Innovation Challenge;
Peter Cox, MB, ChB,
FRCPC(C) DCH (SA) FFARCS(UK) RCPS(C), Clinical Director Critical
Care Medicine at the Hospital for Sick Children;
Charles Denham, MD,
Chairman, Texas Medical Institute of Technology (TMIT) Chairman,
Global Patient Safety Forum;
Michael Henderson, MD,
Chief Quality Officer, Cleveland Clinic Health System;
Andreas Hoeft, Director of
Department of Anesthesiology and Intensive Care Medicine at the
University of Bonn Medical Center;
Joe Kiani, Founder, CEO
and Chairman of the Board of Masimo Corporation;
Narender Kini, MD,
President and CEO of Miami Children's Hospital;
Peter J. Pronovost, MD,
PhD, FCCM, Sr. Vice President for Patient Safety and Quality, Johns
Hopkins Medicine, and Director, the Armstrong Institute for Patient
Safety and Quality;
Michael Ramsay, MD,
Chairman, Department of Anesthesiology, Baylor
University Medical Center President, Baylor Research
Institute;
Keith Ruskin, MD,
Professor of Anesthesiology and Neurosurgery, Yale University School of Medicine;
Howard M. Schapiro, MD, MS
Chairman and Health Care Service Leader, Department of
Anesthesiology, University of
Vermont/Fletcher Allen Health Care;
Aryeh Shander, MD,
Clinical Professor of Anesthesiology, Medicine & Surgery, Mt.
Sinai School of Medicine;
Nathaniel Sims, Cardiac
Anesthesiologist & Physician Advisor to Biomedical Engineering
at Massachusetts General Hospital,
Associate Professor of Anesthesia at Harvard
Medical School;
Bob Stoelting, MD,
President of the Anesthesia Patient Safety Foundation;
Andreas H. Taenzer, MD, MS
Associate Professor of Anesthesiology and Pediatrics, Director of
Pediatric Acute Pain Service, Dartmouth Hitchcock Medical
Center;
AkkeNeel Talsma, PhD, RN, FAAN, Assistant Professor
School of Nursing, Research Investigator School of Medicine, RWJF
Nurse Faculty Scholar Alumni, Director of Perioperative Outcomes
Initiative at the University of
Michigan;
John Ulatowski, MD, PhD,
MBA, Professor and Chairman of the Department of
Anesthesiology/Critical Care Medicine, Vice President and Executive
Medical Director of Johns Hopkins Medicine International at the
Johns Hopkins University School of
Medicine;
Thomas Zeltner, Special
Envoy of the Director General of the World Health Organization
(WHO) in Financing, Former Secretary of State for Health and
Director-General of the Federal Office of Public Health,
Switzerland
1
Daniel R. Levinson, Adverse Events in Hospitals: National Incidence
Among Medicare Beneficiaries, Department of Health and Human
Services Office of the Inspector General, November 2010;
|
2
Kohn LT, Corrigan JM, Donaldson M, eds. To Err Is Human:
Building a Safer Health System. Washington, DC: Institute of
Medicine; 1999, p. 1.
|
3
Marik PE.et.al. Crit Care Med.
2008;36(9):2667-74
|
4
Carson et al. Cochrane Database Syst Rev. 2012 Apr
18;4:CD002042
|
About the Masimo Foundation for Ethics, Innovation and
Competition in Healthcare
Committed to advancing positive change for the benefit of
patients, clinicians, hospitals and payers everywhere. the Masimo
Foundation for Ethics, Innovation, and Competition in Healthcare is
a U.S.-based, private charitable foundation that is focused on
improving patient care, preserving patient dignity and reducing
cost of care, through philanthropic programs and research
initiatives that foster an environment of aligned incentives,
highest level of ethics for those who take part in the care of
patients, and healthy and honest competition. The Masimo Foundation
also helps create pathways for new lifesaving discoveries and
inventions, and improve access to cost-effective, innovative
healthcare solutions. The Foundation's emphasis is on
transformative projects that seek to truly enhance patient safety
and outcomes; helping to forge a world free of sickness, disease
and inhumanity. Masimo Foundation supports third-party research,
development initiatives, and clinical studies designed to expand
the healthcare industry's ability to provide better and more
cost-effective solutions and protocols for healthcare delivery. The
Foundation also gives special attention to causes whose goals are
ethical - focused on doing the right things for the right reasons -
and designed to foster innovation and create healthy competition,
which the Foundation believes is the ultimate answer to improving
care, improving access to care, and lowering healthcare costs in
the United States and around the
world. To learn more about the Masimo Foundation, visit
www.masimofoundation.com.
Forward-Looking Statements
This press release includes forward-looking statements as
defined in Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, in connection with the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on current expectations about
future events affecting us and are subject to risks and
uncertainties, all of which are difficult to predict and many of
which are beyond our control and could cause our actual results to
differ materially and adversely from those expressed in our
forward-looking statements as a result of various risk factors,
including, but not limited to: risks related to our assumptions
regarding the repeatability of clinical results as well as other
factors discussed in the "Risk Factors" section of our most recent
reports filed with the Securities and Exchange Commission
("SEC"), which may be obtained for free at the SEC's website
at www.sec.gov. Although we believe that the expectations reflected
in our forward-looking statements are reasonable, we do not know
whether our expectations will prove correct. All forward-looking
statements included in this press release are expressly qualified
in their entirety by the foregoing cautionary statements. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of today's date. We do not
undertake any obligation to update, amend or clarify these
statements or the "Risk Factors" contained in our most recent
reports filed with the SEC, whether as a result of new information,
future events or otherwise, except as may be required under the
applicable securities laws.
Media Contacts:
Mike
Drummond
Masimo Corporation
Phone: (949) 297-7434
Email: mdrummond@masimo.com
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care... by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC,
SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7,
Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter,
Adaptive Threshold Alarm, and SEDLine are trademarks or registered
trademarks of Masimo Corporation. The use of the trademarks Patient
SafetyNet and PSN is under license from University HealthSystem
Consortium.
SOURCE Masimo Foundation for Ethics, Innovation and Competition
in Healthcare